Cargando…
Fibrinolytic Administration via EkoSonic™ Endovascular System (EKOS) Catheter Used in Acute Aortic Occlusion Secondary to COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 is the virus responsible for the 2019 global pandemic. Pulmonary complications of COVID-19 are well established in the literature. However, the virus causes numerous extrapulmonary manifestations, notably acute aortic occlusion...
Autores principales: | Moynihan, Harrison, Richardson, Jordan, Loveridge, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417098/ https://www.ncbi.nlm.nih.gov/pubmed/34513466 http://dx.doi.org/10.7759/cureus.16893 |
Ejemplares similares
-
Treatment With EkoSonic™ Endovascular System (EKOS®) of Massive Pulmonary Thrombosis Following Recovery From COVID-19 Infection
por: Cetingok, Ugur, et al.
Publicado: (2022) -
The Role of EkoSonic Endovascular System or EKOS® in Pulmonary Embolism
por: Khan, Kashmala, et al.
Publicado: (2019) -
A Case of Failure of EkoSonic™ Endovascular System in the Treatment of Submassive Pulmonary Embolism
por: Tirthani, Ekta, et al.
Publicado: (2021) -
Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter
por: Kennedy, Sonya R., et al.
Publicado: (2023) -
Fibrinolytic administration via EKOS catheter used in pulmonary embolism
por: James, Alana, et al.
Publicado: (2017)